Hereditary Hematological Disorders Development Market Report: Overview of all products in therapeutic development for each indication

. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for thalassemia, hemophilia B and sickle cell anemia, and features dormant and discontinued products.

Pune, India – November 6, 2018 /MarketersMedia/ —

Thalassemia refers to a group of inherited blood disorders that affect the body’s ability to produce hemoglobin and red blood cells. Symptoms include paleness, frequent infections and jaundice. Predisposing factors include family history. Treatment includes blood transfusions and bone marrow transplant. There are 40 products in development for this indication.

Access Report Details at: https://www.themarketreports.com/report/hereditary-hematological-disorders-drug-development-pipeline-review-2018

Sickle cell anemia is a genetic blood disorder in which red blood cells, which carry oxygen around the body, develop abnormally. Signs and symptoms include anemia, delayed growth, vision problems, pain and frequent infections. Treatment includes antibiotics, pain relievers, blood transfusion and stem cell transplant. There are 68 products in development for this indication.

Molecular targets acted on by products in development for hereditary hematological disorders include coagulation factors, histone deacetylases and protein kinases. Companies operating in this pipeline space include Sangamo Therapeutics, Gamida Cell and Bluebird Bio
Scope
• Which companies are the most active within each pipeline?
• Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
• To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
• What are the most important R&D milestones and data publications to have happened in this disease area?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/1319467

Reasons To Buy
• Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
• Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication and a comprehensive picture of recent updates and milestones for each
• Analyze the companies, institutions and universities currently operating in the pipeline and the products being fielded by each of these
• Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Get this report at: https://www.themarketreports.com/report/buy-now/1319467

Contact Info:
Name: Shirish Gupta
Email: Send Email
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/hereditary-hematological-disorders-development-market-report-overview-of-all-products-in-therapeutic-development-for-each-indication/439651

For more information, please visit https://www.themarketreports.com/report/hereditary-hematological-disorders-drug-development-pipeline-review-2018

Source: MarketersMedia

Release ID: 439651